Proteinuria and Hypertension in Patients Treated with Inhibitors of the VEGF Signalling Pathway – Incidence, Mechanisms and Management Cited by

Fol. Biol. 2013, 59, 15-25

https://doi.org/10.14712/fb2013059010015

Proteinuria and Hypertension in Patients Treated with Inhibitors of the VEGF Signalling Pathway – Incidence, Mechanisms and Management

Petra Tesařová¹, V. Tesař²

¹Department of Oncology, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic
²Department of Nephrology, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic

Received August 2012
Accepted September 2012

Crossref Cited-by Linking

Elkaeed Eslam B., Elkady Hazem, Khattab Ahmed M., Yousef Reda G., Al-ghulikah Hanan A., Husein Dalal Z., Ibrahim Ibrahim M., Elkady Mohamed A., Metwaly Ahmed M., Eissa Ibrahim H., Kulig Waldemar: Integrated in silico and in vitro exploration of the anti-VEGFR-2 activities of a semisynthetic xanthine alkaloid inhibiting breast cancer. PLoS ONE 2025, 20, e0316146. <https://doi.org/10.1371/journal.pone.0316146>
Eissa Ibrahim H., Elkady Hazem, Elgammal Walid E., Mahdy Hazem.A., Elkaeed Eslam B., Alsfouk Aisha A., Ibrahim Ibrahim M., Husein Dalal Z., Metwaly Ahmed M.: Integrated in silico and in vitro discovery of a new anticancer thiadiazole analog targeting VEGFR-2. Journal of Molecular Structure 2024, 1312, 138641. <https://doi.org/10.1016/j.molstruc.2024.138641>
Santorsola Mariachiara, Capuozzo Maurizio, Nasti Guglielmo, Sabbatino Francesco, Di Mauro Annabella, Di Mauro Giordana, Vanni Gianluca, Maiolino Piera, Correra Marco, Granata Vincenza, Gualillo Oreste, Berretta Massimiliano, Ottaiano Alessandro: Exploring the Spectrum of VEGF Inhibitors\u2019 Toxicities from Systemic to Intra-Vitreal Usage in Medical Practice. Cancers 2024, 16, 350. <https://doi.org/10.3390/cancers16020350>
Eissa Ibrahim H., Yousef Reda G., Asmaey Mostafa A., Elkady Hazem, Husein Dalal Z., Alsfouk Aisha A., Ibrahim Ibrahim M., Elkady Mohamed A., Elkaeed Eslam B., Metwaly Ahmed M.: Computer-assisted drug discovery (CADD) of an anti-cancer derivative of the theobromine alkaloid inhibiting VEGFR-2. Saudi Pharmaceutical Journal 2023, 31, 101852. <https://doi.org/10.1016/j.jsps.2023.101852>
Elgammal Walid E., Elkady Hazem, Mahdy Hazem A., Husein Dalal Z., Alsfouk Aisha A., Alsfouk Bshra A., Ibrahim Ibrahim M., Elkaeed Eslam B., Metwaly Ahmed M., Eissa Ibrahim H.: Rationale design and synthesis of new apoptotic thiadiazole derivatives targeting VEGFR-2: computational and in vitro studies. RSC Adv. 2023, 13, 35853. <https://doi.org/10.1039/D3RA07562A>
Chehade Hassib, Cachat Francois, Beck-Popovic Maja, Rotman Samuel, Diezi Léonore, Albisetti Manuela, Alberio Lorenzo, Young Guy, Rizzi Mattia: Emicizumab-Induced Seronegative Full-House Lupus Nephritis in a Child. Pediatrics 2020, 146. <https://doi.org/10.1542/peds.2020-0123>
Nakazawa Youya, Kawano Satoshi, Matsui Junji, Funahashi Yasuhiro, Tohyama Osamu, Muto Hiroki, Nakagawa Takayuki, Matsushima Tomohiro: Multitargeting strategy using lenvatinib and golvatinib: Maximizing anti\u2010angiogenesis activity in a preclinical cancer model. Cancer Science 2015, 106, 201. <https://doi.org/10.1111/cas.12581>
Zhang Hai-Liang, Qin Xiao-Jian, Wang Hong-Kai, Gu Wei-Jie, Ma Chun-Guang, Shi Guo-Hai, Zhou Liang-Ping, Ye Ding-Wei: Clinicopathological and prognostic factors for long-term survival in Chinese patients with metastatic renal cell carcinoma treated with sorafenib: a single-center retrospective study. Oncotarget 2015, 6, 36870. <https://doi.org/10.18632/oncotarget.4874>
Peng Ling, Zhao Qiong, Ye Xianghua, Zhou Yun, Hu Danna, Zheng Shusen, Bussolati Benedetta: Incidence and Risk of Proteinuria with Aflibercept in Cancer Patients: A Meta-Analysis. PLoS ONE 2014, 9, e111839. <https://doi.org/10.1371/journal.pone.0111839>